Bad
pharma: The
Pharmaceutical industry’s (pharma) prime
goal is the maximization of profits; thus, public’s health is their hype. I
call this tobacco ethics and science.
To know how broken the system is read Marketing
Science, on the FDA , how doctors
are their pawns, and watch Prof. Angell. The attack on HRT follows the pattern
of
eliminating an off-patent drug that reduces profits especially when they
prevent chronic conditions (see above).
Natural HRT
Benefits vs. Mare’s Urine Estrogen with MPA--the tragic differences
Setting
the record straight Prempro
vs. natural HRT --
for more
Section
II:
Tobaccos Science and Bad Press: Prempro, one of the first HRTs[1], has
been marketed since 1942 by Wyeth Laboratory (bought out by Pfizer in
2009). It has been and still is the
best-selling HRT. A supposedly
definitive study of HRT was done by the FDA’s drug
research branch, National Institute
of Health (NIH) (with
undoubtedly a nod from
pharma). The Women’s Health Initiative (WHI)
knowingly selected the worst
formulation of HRT, Prempro. NIH
had the results of the Hormone Estrogen
Replacement Study (HERS)
UK
completed in 1998 which used Prempro; moreover, earlier studies singled out (medroxyprogesterone)
MPA as the cause for the increased
risk of breast cancer (Goodman
& Gilman 2006, 1552). Prempro
consists of an estrogen cocktail derived from pregnant mare’s urine—7
unique mare estrogens-to
which is added the synthetic progestin MPA.
(The cruel treatment of mares and subsequent
slaughter was broadcast
by Frontline.) “Pregnant mare’s
estrogens are the weak estrone
(>50%), and the two mare estrogens, equilin (15-25%)
and equilenin…. Mare (equine) estrogens such as equilin,
that
are foreign to the human body, have been shown, when compared to other studies,
to have effects that are significantly worse than the natural estradiol[2].” MPA, the synthetic progestin used in
Prempro, blocks most of the beneficial
effects of estrogen--the natural progesterone doesn’t. Using Prempro,
the WHI found that compared to a
placebo there was increased incidents:
heart attacks 29%, breast cancer 26%, pulmonary embolism 113%, strokes
41%, total deaths 15%, all cancers 3%; reduced incidents: hip fractures
34% and colon cancer 37%.”
“MPA antagonizes this athero-protective
effect [arteries, including coronary]” at 1997. Though
“all causes of mortality were not effected”, the press highlighted risks for
HRT (undoubtedly with a nod from their biggest advertiser[3]), &
HRT sales plummeted. The equine estrogen only arm of WHI had better results; more proof that
adding MPA causes the harm. Pfizer in 2010 settled a suit over breast
cancer for $330 million or $150,000 per person.
Yet Prempro is still on the market (thank you FDA & pharma) and still
first in sales. Based on the WHI, NIH
issued this
warning on all HRTs: “…increased risk of myocardial infraction, stroke,
invasive breast cancer, pulmonary emboli, and deep vein thrombosis in
postmenopausal women… Estrogens with or
without progestins should be prescribed at the lowest effective doses and for
the shortest duration consistent with treatment goals…” The warning
is placed on all packages of HRT, and it is accepted
as correct by most doctors and patients. My doubts were confirmed when
attending a
lecture on the WHI given in 2002 at
UCSD by Professor Dr. Robert Langer. He
explained to a large medical audience that the WHI Prempro results cannot be validly
applied to other HRT formulas. Over 50 years of research was not overturned;
rather physicians and the public were tragically misled by the press, pharma, guidelines,
and the NIH. This is another example
of regulatory
capture. Tobacco ethics guides
pharma.
CONFIRMATION: Set Up to Fail
was published in the highly acclaimed science journal, Nature,
09/09/2010: “Is
Nature ignorant of the vital fact
that Prempro contains no
progesterone, but instead the artificial progestogen Provera [MPA]. The other component is Premarin (conjugated estrogen), which is a very
uncertain, patent mixture of substances from the urine of pregnant mares….
[equine (horse urine) estrogens] have crucially different effects. Prempro
is totally
unrepresentative of any other product used for HRT purposes…. . Much
of it was known before the NIH chose to use Prempro in its intended landmark
study. Using a study of the
effects of Prempro to attack the entire use of HRT has, through needless fear, caused
millions of women to forgo
considerable benefits of HRT using better products. This point has been
repeatedly made by
endocrinologists. Why
does Nature not know it?--END OF
ARTICLE.
"I think that it borders on a tragedy that Premarin
and Provera
[the 2 compounds in Prempro] were chosen as the only HRT treatments [for the
WHI Study]”. Another researcher finds
that Provera [MPA]--and no other progestin--blocks the mechanisms that allow
estrogen to fight the brain's immune response to Alzheimer's…. Bruce S. McEwen Neuroendocrinologist of the
Rockefeller University is unequivocally critical of the study: "I think
that it borders on a tragedy that Premarin and Provera were chosen as the only
HRT treatments." “With Medroxyprogesterone
[MPA] in Provera you are
activating two receptors involved with cell division in the breast," she
says, "and that's the culprit, not estrogen [for breast cancer].” Recent
research shows that Provera interferes with estrogen's ability to prevent memory
loss
and dementia. “Estrogen is able to protect neurons
against toxic assaults that are associated with Alzheimer's disease,"
notes Roberta Diaz Brinton, a neuroscientist at the University of Southern
California…. she found “that
Provera--and no other progestin--blocks
the mechanisms that allow estrogen to fight the brain's immune response to
Alzheimer's”. This immune response wears away at brain cells and
causes them to leak neurotransmitters such as glutamate, which overloads and
kills neurons.” Hormone Hysteria,
Scientific
American Sept. 2003. “Premarin,
conjugated estrogen or conjugated equine estrogens[4]. Since it is from a pregnant mare, like with
mothers they make enough of an estrone to block the non-pregnant most
beneficial estradiol, namely estrone.
Thus there is a double whammy that of the progestin which is inferior to
the natural progesterone and the estrone” Wiki Nov 2012.
The 2008 study “Could
transdermal estradiol + progesterone by a sager postmenopausal HRT? A review confirms the criticism of the
WHI studies through an extensive review of existing research, while at the same
time strongly supporting the continued use of HRT in menopausal women because
of lowering the risk of degenerative diseases such as osteoarthritis,
rheumatoid arthritis, cardiovascular disease and their consequences, other benefits
include reduced risk of sarcopenia, osteoporotic fractures, diabetes,
hypertension, cognitive decline, sexual decline, and without the risks caused
by the synthetic HRT such as deep vein thrombosis, pulmonary thromboembolism, and
breast cancer. This study has been lost
in pharma dominated education and guidelines which has turned doctors into
dupes of pharma. Sadly and reluctantly, I have concluded
that medical science has been replaced with marketing pants that is wearing the
language of medical science. Following
the business imperative for quarterly profits pharma applies tobacco science
and tobacco ethics thereby putting profits come before people. We have the greatest
black man-made health
disaster dressed as the miracle of modern science. The number of drugs not worth
their side
effects is the norm. Until the national
data banks for the real-world population are opened, the harm done and benefits
caused by the weird chemicals called drugs
won’t be known. Our high sugar diet has
damaged every cell, and thereby greatly increased our vulnerability
[1]
First was DES
(diethylstilbestrol) a non-steroidal estrogen developed in 1938. Like Fleming
with penicillin, DES was not
patented because Dodds felt that scientists were working for the pubic, and it
was too important to deny cheap
availability
by patenting. Animal studies had in the
1930’s exposed DES serious side effects; but the industry relied upon human trials,
and the FDA on Sept. 19, 1942 approved DES though aware of the more
reliable animal studies. DES was
marketed under 200 brand names. Numerous
claims were made such as producing
healthier babies and preventing miscarriages. In 1971 DES was found to
cause a 40 fold
increase in cervical & vaginal cancers.
Later studies found several internal genital abnormalities in the
daughters and sons of mothers given DES. 26
years later In 1997 Eli Lilly stopped making and
marketing DES. DES was also the standard treatment for advance
prostate cancer for over 40 years. The
other early blockbuster HRT Prempro with
the progestin MPA has been shown to increase
the rate of growth of breast cancer.
So too does nonrethisterone and dienogest, but progesterone induces
apoptosis, at.
[2] Equilin blocks E1 and E2
receptors and thus would reduce the effectiveness of natural estrogens. Though
Prempro and Premarin (just equine
estrogen) are still the world’s leading HRT and ERT, no follow-up research was
done because the financial incentive is to hide side effects.
[3]
Pharma’s assault
on HRT is driven by their profits for
chronic conditions arising from osteoporosis, depression, arthritis, Alzheimer’s
disease and the assorted illnesses
and conditions related to atherosclerosis especially heart attacks, strokes,
and hypertension; an example of tobacco ethics.
[4]
s estrone 51%, equilin 24%, 17 alpha dihydroequilenin 15%, 17-alpha estradiol 4%,
equilenin 3.3%, and estradiol 1.1% at
textbook.
Section III:
BENEFITS OF HRT Why are the sex steroids
(sex hormones) so beneficial for those with hypogonadism? I
lean heavily upon our ancestors living in villages, for most there is incessant
warfare with neighboring villages and/or clans.
The elderly being a burden because of their decline in functions to labor,
produce children, and fight (males), this entails that biological systems that removes
the elderly would be selected for. The
andropause and menopause occur in the 6th promotes their
elimination. Hormonal supplementation
counters the steroids role in the aging process, thereby improving quality of
life.
Mitochondrial
dysfunction: This explains all the
benefits below! Mitochondria have sex
hormone (including DHEA) receptors, that turn up the various processes that “is
mitochondrial protection.” At 2013, Optimal cellular functions entail an
adequate supply of the energy molecule ATP, which is what fats and
carbohydrates are used to make through their conversion acetyl-CoA and pyruvate
produced in the cytosol and then transported into the mitochondria to make the
essential ATP. EVERY PROCESS IN THE BODY RUNS ON ATP. Early, in 2018, I came to the realization
that the long list of conditions associated with the western diet had as a
starting point the reactive sugar fructose damaging mitochondrial DNA. Subsequent
investigation found that the sex
hormones TTT and estradiol are mitochondrial protective re reactive chemicals,
and this is the mechanism behind their long list of benefits. “Both
steroids trigger a complex molecular mechanism that involves crosstalk between
the mitochondria, nucleus, and plasma membrane, and the cytoskeleton plays a
key role in these interactions. The result of this signaling is mitochondrial
protection”, at Sept
2013. “Our
results indicate that testosterone improves cell survival and mitochondrial
membrane potential and reduces nuclear fragmentation and reactive oxygen
species (ROS) generation. These effects
were accompanied by a positive regulation of neuroglobin, an oxygen-binding and
sensor protein, which may serve as a regulator of ROS and nitrogen reactive
species (NOS), . . . these findings
suggest
that astroglia may mediate some of the protective actions of testosterone in
the brain upon pathological conditions” at
June 2016 and similar for cytoprotection and cardiac recovery after MI, at
2004. Overall benefits through
signaling and turning on DNA is covered in an 2011 seminal
article. All three very similar in structure
hormones,
testosterone, DHEA, and estradiol have similar protective functions. Unfortunately,
the industry that profits from
illness has opposed their usage and does tobacco science to “educate”
physicians and the public that hormonal interventions has major “risks” and
minimal benefits, while at the same time ignoring studies that contradict their
findings. We have gone from the golden
age of medicine back to the snake-oil era now dressed in the language of
science and clinical trials. The devil
is buried in pharma’s details. Sadly I have come to realize the corruption worked
by an industry that profits from illness and has created pill pushers and pill
poppers—for some examples, and.
Alzheimer’s disease with past
long-term
HRT, 7 vs
30 control. Estrogen is neuro-protective by inhibiting oxidative damage. Progesterone
is also neuro-protective: used in large
doses following trauma “to limit central nervous system damage.”
Again MPA in WHI study increased risk of dementia, 40 cases of dementia
versus 21 in the placebo group, at. . A
study of hypoxia and DHEA, TTT, and estradiol and their metabolite
epiandrosterone (EPIA) found only EPIA neuro-protective. This helps to explain
why the method why some have failed to find estradiol neuroprotective.
Breast density maintained for women on HRT.
The difference has been repeatedly noted on mammograms.
Cognitive
Function: “There are
plausible biological
mechanisms by which estrogen might lead to improved cognition.” Estradiol surpasses
oxidative stress in the
brain’s mitochondria, thus increasing ATP needed for optimal function, at
2007.
Sexual Satisfaction: prevents vaginal atrophy, “HRT improves sexual function” better,
estradiol &
testosterone, &.
Cancer
breast et al risk decreased: 73% less for estradiol:
“in breast cancer 10 in treated group v 17 in control
group.” HRT after & also during breast cancer
greatly increases
survival, also
ratio 0.28, and 53% increase-results
would be better estradiol with
progesterone. “MPA (in Prempro)
increases the risk of
breast cancer” some progestins increase risk. Contrary to pharma, estradiol progesterone doesn’t
increase
risk, and when given following
breast cancer
over 2/3rd
fewer deaths at 15 years HRT, and also,
also, same
for uterine
cancer. HRT also prevent skin cancer.
Colon cancer: “the
reduction among current users RR = 0.55… users of 11 years or more RR of
0.54 [46% lower, also].” Estrogen
and progesterone have beneficial
effects for “esophagus, stomach, gallbladder, and intestines.”
Breast cancer survival: “Cancers in women who use HRT are often less advanced,
and lower mortality has been reported in those who use HRT than in nonusers… The
association of HRT with lower
proliferation rate and smaller tumor size was exclusively caused by ER-positive
tumors” at. After diagnosis 72% higher survival: “The risk of
death was lower among the HRT survivors; odds ratio 0.28…” at, Also, breast cancer mortality rate of 5 per
1000 person years in HRT users compared to 15 in nonusers, at. This was explained,
along with the fact that women post-menopausal women on estradiol and those were
pregnant have a lower risk of breast
cancer in that their estradiol and estriol blocker estrone (E1) stimulates
cancer growth—at 1974.
For negative results, pharma used the progestin MPA (WHI study) which
blocks the cancer protecting and CVD
protecting effects of estradiol; other progestins could be similar; however,
“progesterone combined with estradiol induces apoptosis [cancer cell death]” at. So rather than go after the block buster
culprit estrone with E1-3-MTP (at 1993),
pharma blocks both estradiol its health benefits and estrone.
Cardiovascular disease (CVD) &
MI: “estrogen lowered … 37%
LDL …, extends life 2.1 years,”
Braunwald, Heart Disease 5th Ed, 97, p 1708. “HRT decreases CAD morbidity and CAD mortality
… was 0.56 compared to subjects not
taking estrogen” Braunwald 1142; another 50%, 16 vs 33, reduction in CHD. Estradiol blocks
oxidation of LDL to prevent atherosclerosis. “Estradiol completely
reverses the effects induced by OX-LDL on the DDAH/ADMA/NO pathway,” Avoid MPA and LNG (levonorgestrel). Another
study found 26 MI deaths for estradiol vs. 56 for placebo (115%).
A meta-study found and a 50% reduction of
Coronary Heart Disease. Lowers hypertension risk. Two AHA studies explain
mechanisms of cardio arteries protection and Wiki, also, Angina pain is associated with low
estrogen, treated. Calcification of arteries is strongly
associated with MI. HRT lower calcification
of coronary arteries—at, using Prempro.
Cholesterol
effects, percentage of reduction in LDL with E 37%, with E + PA 46% (E is
equine estrogen and PA is medroxyprogesterone Braunwald, Ed 6, Table
51-2). Estrogen significantly protect
LDL from oxidation at
. “E2
at a concentration of 1 μmol/L inhibited LDL oxidation by 37% to 62% at the
various concentrations of copper” at.
Oxidized LDL in the tunica media of the
artery is held to by pharma to be the major cause for atherosclerosis and CVD.
I DO NOT SUBSCRIBE TO THE LIPID
HYPOTHESIS,
statins are poison, wrong cause, and more, expert’s review on statins
as poison.
Diabesity,
which is both Obesity & Diabetes: the
drop of estradiol increases LPL which
regulates weight, distribution of fat, and activity. Gary Taubes, Good Calories, Bad Calories,
398, Taubes Why we Get Fat, 90-91,
and Wade at, In the obese estrone is +40% at. Weight related issues (metabolic syndrome, insulin resistance, & diabetes) are
associated with drop in estradiol, at. Likely mechanism is a reduction in the related
hormone DHEA whose metabolite (7-oxo-DHEA) promotes significant weight loss (at)
and is neuroprotective (at). Note, JK takes DHEA 40 mg sublingually;
it diminished
appetite for one hour, mild stimulant and avoid first–pass over 95% metabolism
by the liver which occurs with oral dose, no additional weight gain.
Endothelial
cell dysfunction prevented, the compromised performance of the single
layer of squamous cells lining all the blood that form an interface between
circulating blood content and interior tissue.
Their under-performance is responsible for over 95% of all cardiovascular
disease. Estradiol significant improves
the performance of these cells at 1996,
1996. “Hormone replacement with estrogen has been
shown to improve endothelium-dependent vaso-relaxation acutely in a number of
animal models, including primate coronary arteries (97)”
at 1999—relaxation a measure
of health. “Endothelial function is abnormal
in many postmenopausal women compared
with premenopausal women, and in some postmenopausal women it can be enhanced
by estrogen
replacement therapy. This effect may increase with prolonged use”
June 1998.
Longevity: Telomere numbers of units on the end of DNA are essential
for cell longevity and functionality—see Wiki.
It has been shown both in
animal and human studies that treatment with estradiol lengthens through action
on telomerase the number of telomere units, see careful matched study of HT
therapy, and, and, and,
for animals. This
action on telomerase in part explains the many benefits from estradiol as to
the protective effect in mitochondria.
Macular
degeneration, and hearing: HRT resulted
in a 36% reduction and other eye pathologies. Hearing
better.
Mental Health:
Estradiol like several hormones (DHEA and testosterone
and
probably others) have receptors in some
of the cells in the brain. For example, DHEA is produced in the brain. “Estradiol
has been found to be effective in the adjunctive treatment
of schizophrenia in women. It has been found to significantly reduce positive, negative, and cognitive symptoms, with particular benefits on positive symptoms.” Wiki 4/19.
Mitochondrial
protection as antioxidant: “Estrogens
have antioxidant properties which are due to their ability to bind to estrogen
receptors and to up-regulate the expression of antioxidant enzymes via
intracellular signaling pathways. . . . Recently, estrogen receptors were identified
in mitochondria at
2010. This function is at the heart of E2 benefits.
Mood elevation
and depression: “Numerous molecular and clinical studies have implicated estrogen in
modulating brain function including that related to mood,” treatment of mood disorders and
depression no
additional weight
gain.
NAFLD: “Non-alcoholic
fatty liver disease) is
also more common among men than women in all age groups until age 60, where the
prevalence between sexes equalize. This
is due to the protective nature of estrogen,” Wiki.—
diet's role.
Neurosteroids: “These
brain-mainly glia cells produces sex steroids that are labeled “neurosteroids”,
and have been found to exert important regulatory functions” at
2008. Among the neurosteroids
are pregnenolone, estradiol, testosterone, and DHEA and their storage form such
as DHEAS and pregnenolone sulfate. Those
just listed I have I have extensively reviewed their literature. There are over
a dozen other neurosteroids. As a senior I take sublingually or in lotion
3 of those hormones. They reduce the
risk of for age related neurodegenerative conditions and slow the rate of
cognitive decline (contrary to pharma’s warnings and the belief of most
physicians).
Osteoporosis and bone remodeling:
“Bone loss increases after menopause due to lower levels of estrogen.,. [causes removal of
ovaries” Wiki “Esterified
estrogens produced significant increases
in bone mineral density (lumbar spine, hip).
54.2%
greater spinal mineral. “1
of 4 white
women over the age of 60 had spinal compression fractures associated with
osteoporosis. One
woman of 5 will fracture a hip by the age of 90,” and even more will have knee
replacement operations. Bone gain from long-term
HRT, also;
estradiol's
role. Numerous journal articles hold that progesterone work with estradiol
to increase remodeling of bone, at, and, and. Estradiol slows the loss of bone calcium and
progesterone increase the rate of calcium replacement. Bisphosphonates drugs
increase bone density
by adding unnatural phosphate to the bones which result in an increased brittleness,
and “they disrupt intracellular enzymatic functions needed for bone
resorption” and they have other major side
effects. Including atrial fibrillation.
Osteoarthritis (OA): When both incident and progressive
radiographic knee OA
cases combined, “current ERT [estrogen only replacement therapy] use had a 60% decreased risk compared with never use”. Progesterone is most important.
Rheumatoid Arthritis (RA):
“HRT was well tolerated, increased
well-being, reduced articular index and increased lumbar spine bone density
over a one year period in postmenopausal women with RA” also,
& lowers RA CVD deaths.
Parkinson’s disease,” loss of estrogen resulted in decrease
neuron
density in the substantia nigra (structure of brain damaged by Parkinson’s
disease), and restoration of estrogen in increased density” at, and. Again MPA exacerbates condition & risk, at. Pharma of course does junk science to show
that HRT does not affect the course of the disease.
Programed death & longevity through menopause is to remove elderly women from the community,
thus
the precipitous decline in health of
women after menopause. To slow
this process requires the taking of natural HRT.
Sarcopenia
age related
loss of skeletal muscle mass with age is associated with low level of estrogen
& testosterone in 22.6%
in older postmenopausal women not receiving estrogen or TTT. TTT
prevents and
reverses sarcopenia, and;
however HRT alone does
not protect against muscle loss which is why I would add TTT to the
compounded formal. About 10% of estradiol is
converted to testosterone by the body for its androgen (muscle building) effect.
Skin
healthier American Journal of Clinical Dermatology & more hair, hair, hair. “Studies of
postmenopausal women indicate that estrogen
deprivation is associated with dryness, atrophy, fine
wrinkling, poor healing, epidermal thinning, declining dermal collagen content,
diminished skin moisture. The decrease was preventable by the use of HRT.” “The mean collagen content in the skin was … found
to be 48% greater”,
slows
skin aging, also, and less skin
cancer, 2008.
Urinary Tract
Infections Recurrent (UTI), also urinary urgency, urogenital & vaginal
atrophy are associated
with low estrogen in post-menopausal women.
A meta-analysis
of 8 quality studies found the placebo group 2.5 times more likely to have
a subsequent UTI. Topical
administration most effective; however for vaginal
atrophy estradiol tablets.
Venus Thrombosis: an 8% reduction in risk of with esterified
estrogen while those on
Prempro had a 65% elevated risk JAMA
04, and; a 23% reduction exogenous
estrogen (5.1% of cases versus 6.3% control cohort).
10 Reasons for
HRT: Menopause Int. & Oncology:
Both list the above benefits, and the latter
advises HRT for survivors of breast cancer because of “a 70% reduction in
the risk of death” during the 15 years, also.
The 4 other major sex hormones (DHEA,
progesterone, testosterone, and pregnenolone): What
is said of estradiol as to positive effects applies to testosterone, they follow
a similar evolutionary path, but for the degree of androgen effect (only about
10% of estrogen is converted to testosterone, thus its lower androgen
effect). In general, the cell
types which have estrogen
receptors have receptors for other
sex steroids, and often the combination is superior to supplementation with just
one of those steroids—see below recommendations.
Section IV, What I
would do if a woman: NHRT is part of nature’s
clock. NHRT sets the body’s
clock to premenopausal and thereby reduces the
rise for age-related chronic conditions.
The low level of estradiol causes
the precipitous decline after menopause.
Average life extension with long-term NHRT is over 6 year
based on above benefits and the Danish long-term trial,
which the BMJ reprinted a decade later to get the message out. NHRT
must be applied topically as a cream
from a compounding pharmacy and not as a pill, since when taken orally the
nutrients and other substances absorbed by the intestines travel through the
hepatic portal vein to the liver where the estradiol is converted to estrone,
the contraceptive form of estrogen.
Estrone goes to the ER-alpha and ER-beta estrogen receptors and blocks
estradiol activity. The creams should
contain at least 5 mg of estradiol and
100 of progesterone since absorptions
are but 10%. If some is applied
vaginally, the absorption is about 30%.
My former wife uses 30-gram of 0.15% monthly of lotion from the
compounding pharmacy to which she applies 1/4th teaspoon (1 grams)
over her upper torso while still wet following her shower (this permits by
spreading out the lotion better absorption). If concerned about muscle strength, add 30 mg
of testosterone in lotion
to reverse sarcopenia,
androgen deficiency, & to improve libido
without
reduction in estradiol. Wikipedia
(4/19) lists bioavailability of E2 at <5%. The same applies to the other
sex steroids. I take testosterone since 2004 topically as
cream 375 mg daily, and DHEA sublingually 100 mg since 2002. 60% of estradiol
is bound to albumin and 38%
to SJBG, and 2% is free. Pregnenolone and DHEA are stored as sulfates,
and the others are bound on proteins.
What to avoid and why: True to profits-first,
corporate tobacco
ethics, pharma offers 1) HRT in too low a dose; 2) Some oral formulations of
estrogen don’t deliver estradiol, but rather the inferior estriol—which works
as birth control, but blocks estradiol healthful benefits; 3) synthetic
estrogens, horse estrogen, and synthetic progesterone (progestins) of
questionable value and safety; 4) Avoid pharma’s HRT in that they are probably
too low a dose and other tricks. For
example, in the US, Novo Nordisk markets is Vagifem, a vaginal inser; it is 10
mcg (yes, micrograms, 1/10th of a mg) of estradiol. At that dose it possible reduces vaginal
atrophy, but certainly won’t reduce risk for ischemic events, cancer,
Alzheimer’s diseases and so on. Their Nor
Disc pills marketed in 1990 had 2 mgs of estradiol; it in a 11 year follow-up
had 15 deaths compared
to 26 in the placebo group. Prescription HRTs are likely to be too low a dose and/or
with a pathogenic progestin. See what my
ex-wife takes below, a better choice; 5) human estrogens estrone (E1), Estriol
(E3), estetrol (E4) which are less bioactive and they block some of the action of
estradiol, the best estrogen. Most
doctors will look on their computer and prescribe as a compounded lotion E3, E2,
and progesterone. E3 blocks the benefits
of E2 and has the side effects of tender breasts and nausea.[1] Probably the same with the addition
of E1 and E4; 6) Physicians responding to a patient’s request for compounded
lotion will likely use their computer for the formula. It will consist of a
cream which will have
both E2 and E3. E3 blocks E2, and causes
blotting and other side effects. I have
received reports from both Canada and the US of patients getting the same
combination—thank you, pharma; 7). For hot flashes, NIH guidelines include a
major tranquilizer (SSRI),estrogen blockers such as Tamoxifen, the
bisphosphonate Fosamax, estrone (as Estragyn) which is a very weak from of
estrogen that blocks estradiol, and Ropinirole a dopamine agonist thus promotes
lethargy and depression—all of them have made my do not take list.
“Current research
shows that the transdermal route of estradiol administration
can also be advantageous for women with diabetes, hypertension and other cardiovascular
risk factors, as those risks increase with advancing age” Wiki 2018,
at
2013, 2008.
“Oral HRT is associated with an increased risk
of venous thromboembolism (VTE), gallbladder disease and possibly stroke. The
increased occurrence of all these events
can be prevented by the use of the transdermal route of estradiol
administration; this route seems also advantageous for women with diabetes,
hypertension and other cardiovascular risk factors, and also especially with
advancing age” at.
This doesn’t apply to transdermal application
which avoids the high level of metabolic products generated by the liver that
are causal for those events, at
2008. If I was a woman, I would tell
my physician I don’t believe those risk apply to NHRT, and what risks there
are is outweigh by benefits, then give
him a copy 2010 journal article. There is a major difference between a pill
and a lotion, due to the action of the liver upon estradiol when taken orally. I’d
tell him I observed the benefits in a
friend & a relative and want the same.
Beware of hormone balancing; some doctors are milking the
patient. The evidence for this is weak
for postmenopausal women. Avoid
“bio-identical” plant estrogens and progesterones—they aren’t identical to
human sex hormones. These hormones occupy receptors with uncertain
action and possible block benefits, like MPA, and most have low
bio-availability and even lower bioactivity.
The evidence for sequential HRT is moderate, but it has a lower
compliance because of vaginal bleeding (at 1997) and
it must be taken as a pill which entails the conversion of estradiol to estrone
(see above). There is a lack of quality clinical
trials on them.[2]
However, both hormone balance and
sequential HRT are significantly better than going without HRT. Estrogen
is
involved in both weight regulation and fat distribution. Low estrogen entails
for most a gain in
unhealthy visceral (adnominal) fat. Reset
your bio-clock with NHRT, fix your diet, learn about the corruption caused by pharma (on YouTube), and why doctors are
their pharma’s pawns. For testimonials and more on osteoporosis,
link.
Some of the neuroleptic psychiatric
drugs promote significantly catabolism of E2 (and possible other estrogens) through
upregulation of P-450 cytochrome, therefore a higher dose would be needed for
the estrogens. The research was only on
a few of those drugs, at
P 290. Though another topic, in most
cases it is best to avoid the neuroleptic drugs—another topic. If you
must use drugs to reduce boredom and
desire to reduce cognitive functions, it is better to use marijuana. Finally,
it is best to
stay clear of pharma’s
HRT; the last time I looked at what was offered (2015), I wasn’t pleased. In
an era of search for drugs, there are 197
pounds listed in Wikipedia that are hormones, hormone derivates, or have hormonal
action; a gross example of searching for products. There are 159 combinations
of hormones,
130 estrogen
esters, and 67 estrogens. Money shouts, and basic science
whimpers. Not surprisingly with pharma intrusion
into education, doctors are
dupes of pharma, thus they are true believers who don’t know what is best
or harmful.
[2]
“There
is weak evidence that the human body can convert its active ingredient. And
they are sometime not natural: diosgenin, the plant steroid,
is chemically
converted to produce several steroid and sold as natural, see Wiki, and
for more on progesterone, Dr. Lee.
Moreover, these natural chemical are generally not tested on animals for
toxicity, or purified to remove other compounds in the plant extract. For a
big window on plant toxins see the work
of Prof. Bruce Ames, his links, very possible the
leading authority.
^^^^^^^ Non-technical
summation
^^^^^^^^
Natural Estrogen (Estradiol) with
progesterone NHRT: What
every woman should be taking because of the numerous, major health benefits,
benefits that would slash pharma’s profits.
Of the 4 natural estrogens only estradiol (E2) has major health
benefits. Two--estriol (E3) and estetrol
(E4)--are found in pregnant women and block
estradiol. Unfortunately for women, the
addition of E3 to E2 (estradiol) in compounded formulas has made the computer
of physicians and is commonly included in the prescription. This inclusion blocks
the positive effects
and increases side effects—more workings of pharma’s KOLs. Big pharma being
against hormone replacement therapy (HRT) markets ineffective products including
those containing estriol and estetrol, and estradiol at too low a dose &
with inferior progestins such as in the best-selling Prempro. Prempro, a combination of estrogen derived
from pregnant mare’s urine and the progestin MPA. The biological effects
of mare’s estrogens
are different than human estrogen and MPA
blocks most of the positive effects of estrogen. Thus, the results of the
major WHI study
funded by the FDA apply only for Prempro[1]. Nevertheless, the FDA warns that HRT has only
one valid medical use, to manage hot flashes, and should be used at the lowest
dose for the shortest time. Thus pharma
has used marketing science & guidelines to overturn 4 decades of positive
results for HRT: Alzheimer’s 83%, Heart attacks 51%, Coronary Heart Disease 50%,
Colorectal Cancer 46%, Breast Cancer 73%, Thrombosis 8%, Macular Degeneration
65%, osteoporosis fractures 90%, & prevents arthritic join destruction, firmer
breasts, healthier skin (less wrinkles, thicker, 48% more
collagen), reduces hair loss, improved cognitive function, less
depression and mental illness, and a general feeling of well-being with increased
libido. These results occur
because estrogen & progesterone receptors set the body to “premenopausal”
maintenance. Tribal survival benefits from
elimination of the elderly, thus we have the reduction in testosterone and
estradiol to promote that end. The
lack of estradiol (and possible
progesterone) causes the precipitous decline in health of women after menopause.
Life extension with long-term NHRT is over 6 years, and twice that with a low sugar diet. Progesterone (P4), the major progestogen, is
similar to estrogen--they work together.
It has numerous benefits, while some of the
artificial progestins are clearly harmful (such as stimulating the growth of breast
cancer). “Synthetic progestins
often interact with and transactivate androgen,
mineralocorticoid, glucocorticoid or growth hormone receptors”, at
2008, and none have been adequately
researched as to side effects. Like testosterone, estradiol taken at higher
dose has more benefits (this is distinguished from oral estrogens which prevent
pregnancy by producing effects like in pregnancy, which is why a lower dose is
better tolerated.) A sufficient dose is
available only from a compounding
pharmacy (15 mg of estradiol plus 100 mg of progesterone) in a lotion obtained
per application (there is a 10% absorption rate with
topical hormones). For a month’s supply
have prepared 60 gram of lotion,
application of 1/4th teaspoon which is 2 grams. Apply
widely
as possible over the torso, back, shoulders, underarms, and face using
water and rubbing it in to promote better absorption. Ideal free-serum estradiol level
is 200-500 pmol/L. Plant
sources for HRT are not natural and are metabolized by the liver on first pass
from the digestive system. These hormone
mimics fail to perform well and have adverse consequences (see MPA above). The
mimic can occupy sites that estradiol would
go to and block its action. Doctors who
follow the Wiley Protocol are other methods of hormone balancing for post menopause
women are milking the insurance and patient, and it lacks convincing scientific
evidence.
“Current research shows that the transdermal
route of estradiol administration can also be advantageous for women with
diabetes, hypertension and other cardiovascular risk factors, as those risks
increase with advancing age.[4]
Wiki 2018, and at 2013.
“Oral HRT
is associated with an increased risk of venous
thromboembolism (VTE), gallbladder disease and possibly stroke. The increased
occurrence of all these events can be prevented by the use of the transdermal
route of estradiol administration; this route seems also advantageous for women
with diabetes, hypertension and other cardiovascular risk factors, and also
especially with advancing age” at. Tell your
physician you are aware
of risks and are convinced of benefits of NHRT
applied topically is safe; then give him a copy 2010 journal article.
Tell him you observed the benefits in a
friend & a relative and want the same.
Most doctors will comply with your
request.
Lotion from compounding pharmacy of 5 mg estriol and 100 mg of progesterone
[1] Prempro has been the leading selling
HRT
since the mid 40s in the US, and it still is.
The issues with MPA and mare’s urine estrogens has been known for
decades by scientist including those in the FDA as inferior of the other HRT
& natural HRT. Because of birth
control pills, HRT, and the possibility that an estrogen would protect men—as
it does women—from cardiovascular disease, there has been thousands of
published articles on the estrogen and progesterone family of hormones. Unfortunately
the FDA acts to promote
products for pharma while minimally regulating in the public’s interest—see
Consumer Report’s article,
and also.
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
http://www.maturitas.org/article/S0378-5122%2805%2900005-8/abstract
Maturitas, the European Menopause Journal. Vol 53, Issue 1
pgs 11-18, 10 January 2006
Treatment with
percutanous testosterone gel in postmenopausal women with decreased libido –
effects on sexuality and psychological general well-being
Abstract
Objectives
To elucidate if percutanous treatment with 10mg
testosterone per day could enhance sexuality and psychological
well-being in postmenopausal women presenting problems with low libido.
Secondary to study the influence on blood lipids, hemoglobin and erythropoietin
levels.
Methods
Fifty-three postmenopausal women participated. As a complement
to their
already on-going HRT, 10mg
of a testosterone gel (Testogel, Besins–Iscovesco) or placebo was administered.
Treatment continued for three plus three months in a double blind, randomized,
crossover design.
Results
The scores concerning “frequency
of sexual activity,
orgasm and intercourse”, “sexual arousal, fantasies and enjoyment”,
“satisfaction with orgasms”, and “interest in sex” were all significally
improved for testosterone addition as compared to placebo both before
and after crossover. Testosterone
levels increased more than 10-fold during
treatment while DHT-levels were more than doubled. Estrogen levels were not
affected during the addition of testosterone. Liver enzymes, total cholesterol, triglycerides, HDL and LDL revealed
no significant differences between any of the periods or groups.
Endometrial thickness did not change significantly during treatment. Hemoglobin
and erythropoietin remained unchanged. No significant differences in the number
of experienced side effects were found.
Conclusion
Testosterone gel of 10mg
had positive effects on several aspects of sexual life such as frequency of
sexual activity, orgasm, arousal, fantasies and sexual interest in
postmenopausal women on HRT. Several psychological variables were positively
influenced. The given dose resulted in too high serum levels. Even if no
negative effects were observed, monitoring of serum levels and a decreased dose
should be considered in future studies.
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
http://en.wikipedia.org/wiki/Medroxyprogesterone_acetate
The Women's
Health Initiative investigated
the use of MPA and conjugated
equine estrogens compared
to placebo. The study was prematurely terminated when previously unexpected
risks were discovered, specifically the finding that though the all-cause
mortality was not affected by the hormone therapy, the benefits of the hormone
replacement therapy (reduced risk of hip
fracture, colorectal and endometrial
cancer and all other
causes of death) were offset by
increased risk of coronary
heart disease, breast
cancer, strokes and pulmonary
embolism. MPA increases the risk of
breast cancer, dementia and thrombus when used in combination with conjugated
equine estrogens to treat the
symptoms of menopause.[3]
MPA is associated with an
increase in depression. MPA may
cause adrenal
suppression and interfere
with carbohydrate metabolism but
does not cause diabetes.
MPA can cause weight gain, worsen diabetes
mellitus and edema (particularly
of the face). MPA may cause reduced bone
density.
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
Mathew Allison, UCTV
lecture: Nurse’s Study 1985,
Kaiser
Walnut Creek 1987, L.R.C 1988, Leisure World, 1988. All higher dose (2-4x
current), & mostly unopposed (no progestin), reduction in CVD was RR of .3,
.5, .3, & .4 respectively. However,
later studies Uppsala, 1992, and Nurse’s 2000 using opposed estrogen and lower
dose .8 & .75. From RD Langer.
legend meets reality, estrogen plus
progestin and coronary heart disease in the Women’s Health Initiative,
Menopausal Medicine 2003; 10(4): 5-7.
Mathew made no mention of difference of Prempro, and of MPA as to their
differences. Mathew
points out that
the trial was stopped early because of harm caused, and he also shows that the
RR for death was .98. He never commented
how this result doesn’t justify stopping the trial early.
The
estrogen only group has a marked drop in coronary events in years 7-9, 20 vs
41.
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
http://web.a.ebscohost.com/abstract?direct=true&profile=ehost&scope=site&authtype=crawler&jrnl=19369719&AN=42516498&h=PwmKxsowz3PdEJ3N%2fotg0CgClyK%2fJ0tJNaU46NKochWSjNs3oupHKnWke3j4fiB0hoY30kznh3LGJgxO3bXFMQ%3d%3d&crl=c
What Can We Learn
from
Design Faults in the Women's Health Initiative Randomized Clinical Trial?
Points out that by including in
the study a large number of women, up to age 74, that it was an atypical
population and thus deluded the benefit of women free of CVD, those most likely
to take HRT and would show the greatest CVD benefit.
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
RD Langer.
: legend meets reality, estrogen plus progestin and coronary heart disease in
the Women’s Health Initiative, Menopausal Medicine 2003; 10(4): 5-7—NOT
AVAILABLE THROUGH GOOGLE SCHOLAR
|